In a Law360 article published on Feb. 12, health care partner Deborah Kantar Gardner (Boston) examines various state efforts to control drug prices and the constitutional and federal limits on those reforms.
The authors explain that state drug pricing laws take a variety of forms, ranging from importation to rate setting to price transparency. While states have pressed forward with creative and targeted initiatives aimed at reducing drug costs, constitutional and federal authority often impedes their ability to implement fully the reforms they seek.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.